A facial beauty composition containing stem cell exosomes and its preparation method and application

By adding prostaglandin E2 and IL-4 to mesenchymal stem cell culture medium and optimizing the source of lipopolysaccharides, efficient exosomes are prepared for whitening and skin care products, which significantly improves the inhibition of melanin synthesis and skin moisturizing effects, solving the problem of The problem of insufficient whitening effect of exosomes in the prior art is to be found.

CN118576532BActive Publication Date: 2024-11-26BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411061308.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-26
Estimated Expiration
2044-08-05

AI Technical Summary

Technical Problem

The application effect of existing mesenchymal stem cell-derived exosomes in skin whitening and skin care products has not been optimized, and the ability to inhibit melanin synthesis is insufficient.

Method used

Highly efficient exosomes are prepared by adding prostaglandin E2 and IL-4 to mesenchymal stem cell culture medium, combining lipopolysaccharides, and the whitening and moisturizing effect of exosomes is improved through specific concentration adjustment and LPS source optimization. . Specific methods include collecting culture supernatant when the cell convergence reaches 80-90%, isolating exosomes, and mixing it with avocado resin, jojoba oil, sorbitan olive oleate and xanthan gum in skin care products. use.

Benefits of technology

It significantly improves the inhibitory ability of melanin synthesis and skin moisturizing effect, and improves the whitening and moisturizing properties of skin care products. In particular, exosomes prepared through LPS from Pseudomonas aeruginosa show stronger inhibitory ability and whitening effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118576532B_ABST
    Figure CN118576532B_ABST
Patent Text Reader

Abstract

The present invention provides a facial beauty composition containing stem cell exosomes, a preparation method and application thereof, belonging to the technical field of beauty compositions, comprising exosomes from mesenchymal stem cells and cosmetic excipients, wherein the exosomes are prepared by the following method: 1) culturing the mesenchymal stem cells in a culture medium containing prostaglandin E2 and IL-4 until the cell confluence reaches 80-90%, and then performing cell passage inoculation; 2) continuing to culture the mesenchymal stem cells after passage, collecting the culture supernatant when the cell confluence is 60-70%, and separating the exosomes from the culture supernatant. The present invention also provides a preparation method of the facial beauty composition and its application in whitening and moisturizing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a facial beauty composition, in particular to a facial beauty composition comprising exosomes from mesenchymal stem cells, a preparation method of the facial beauty composition and applications in skin whitening and moisturizing. Background Art

[0002] For oriental women, whitening, especially facial whitening, has always been their main functional demand for cosmetics. Therefore, finding substances with whitening and skin care effects has become the focus of research in the cosmetics industry. Common whitening skin care products can achieve the purpose of whitening by adding various functional ingredients with whitening activity. These functional active ingredients can inhibit the formation of melanin by inhibiting the activity of tyrosinase; or inhibit the formation of melanin by inhibiting the division of melanocytes and reducing the number of melanocytes.

[0003] The application of exosomes derived from mesenchymal stem cells in skin whitening has been reported in the art. For example, CN107007541A reports the application of exosomes derived from mesenchymal stem cells in skin whitening preparations. However, the whitening effect of these exosomes needs to be further improved. Summary of the invention

[0004] In one aspect, the present invention provides a facial beauty composition, comprising exosomes from mesenchymal stem cells and cosmetic excipients, wherein the exosomes are prepared by the following method:

[0005] 1) culturing the mesenchymal stem cells in a culture medium containing prostaglandin E2 and IL-4 until the cell confluence reaches 80-90%, and then performing cell subculturing;

[0006] 2) continuing to culture the mesenchymal stem cells after passage, collecting the culture supernatant when the cell confluence is 60-70%, and isolating the exosomes from the culture supernatant.

[0007] In some embodiments, the mesenchymal stem cells are human bone marrow mesenchymal stem cells.

[0008] In some embodiments, lipopolysaccharide is further added to the culture medium during the first two days of cell culture in step 1).

[0009] In some embodiments, the lipopolysaccharide is from Pseudomonas aeruginosa.

[0010] In some embodiments, prostaglandin E2 is used in the culture medium at a concentration of 0.1-1 μM, IL-4 is used in the culture medium at a concentration of 40-100 nM, and lipopolysaccharide is used in the culture medium at a concentration of 50-200 ng / mL.

[0011] In some embodiments, 100 mL of the facial beauty composition includes: 5 g of avocado butter, 15 g of jojoba oil, 8 g of sorbitan olivate, 2 g of xanthan gum, 10 mL of the exosomes, and the balance is deionized water, wherein the concentration of the exosomes is 20 mg / L based on the protein concentration determined by the BrandFord method.

[0012] In another aspect, provided herein is a method for preparing a facial cosmetic composition, comprising:

[0013] S1: Preparation of exosomes, including:

[0014] 1) Cultivate mesenchymal stem cells in a medium containing prostaglandin E2 and IL-4 until the cell confluence reaches 80-90%, then perform cell subculture;

[0015] 2) continuing to culture the mesenchymal stem cells after passage, collecting the culture supernatant when the cell confluence is 60-70%, isolating exosomes from the culture supernatant, and adjusting the exosome concentration to 20 mg / L in terms of protein concentration determined by the BrandFord method using PBS buffer; and

[0016] S2: Preparing a skin care product comprising the exosomes, comprising:

[0017] 5 g of avocado butter, 15 g of jojoba oil, 8 g of sorbitan olivate, 2 g of xanthan gum, 10 mL of the exosomes and deionized water were mixed evenly, wherein the amount of deionized water was such that the total amount of the skin care product was 100 mL.

[0018] In some embodiments, lipopolysaccharide is further added to the culture medium during the first two days of cell culture in step 1).

[0019] In another aspect, the present invention provides use of the facial cosmetic composition for skin whitening and / or moisturizing. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 The results show that exosomes prepared by different preparation methods inhibit melanin synthesis in mouse melanoma cells.

[0021] Figure 2 The results show that exosomes prepared with LPS from different sources inhibit melanin synthesis in mouse melanoma cells.

[0022] Figure 3 The effect of the skin care product of the present invention on the skin MI value is shown.

[0023] Figure 4The effect of the skin care product of the present invention on the ITA° value of the skin is shown.

[0024] Figure 5 The effect of the skin care product of the present invention on the TEWL value of the skin is shown. DETAILED DESCRIPTION

[0025] Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art.

[0026] The inventors found in previous studies that adding prostaglandins PGE2 and IL-4 to the mesenchymal stem cell culture medium can enhance the effect of the prepared exosomes in treating dry eye and relieving eye fatigue, and further adding lipopolysaccharide (LPS) can further enhance the effect (the relevant technical solutions of this discovery are sought for protection in another patent application). Subsequently, the inventors also found that the exosomes prepared by this method have facial beauty effects, including whitening and moisturizing effects. At the same time, the inventors have further optimized the source of LPS in the preparation method to enhance the facial beauty effect of the prepared exosomes.

[0027] The present invention is described below by means of specific examples.

[0028] Example 1 Mesenchymal stem cell culture and exosome preparation

[0029] Human bone marrow-derived mesenchymal stem cells (PT-2501, Lonza) were cultured at 3 x 10 4 Cells / cm 2The cells were inoculated at a density of 100 μg / mL in a T-75 cell culture flask and cultured in an incubator at 37°C and 5% CO2 using MSCGM-CD™ medium (hereinafter referred to as the first generation culture). When the cell confluence reached 80-90%, the cells were digested with 0.25% trypsin and then passaged at the same cell density. The cells were cultured in the same medium and conditions (hereinafter referred to as the second generation culture) for about 3 days (when the cell confluence was about 60-70%), and the supernatant was collected. At 4°C, 100 mL of the collected supernatant was centrifuged at 800 g for 10 minutes to collect the supernatant; the supernatant was centrifuged at 2,000 g for 10 minutes to collect the supernatant; the supernatant was centrifuged at 15,000 g for 30 minutes to collect the supernatant; the supernatant was centrifuged at 150,000 g for 30 minutes to collect the precipitate, which was resuspended in 20 mL of PBS buffer; the precipitate was centrifuged at 150,000 g for 30 minutes to collect the precipitate, which was resuspended in 1 mL of PBS buffer to obtain mesenchymal stem cell-derived exosomes. Scanning electron microscopy showed that the particles were roughly round or oval, with diameters ranging from about 50 to 150 nm. Immunoblotting confirmed that the prepared exosomes expressed transmembrane proteins CD9, CD63, and CD81, but did not express protein Calnexin. The exosome concentration was determined by the BrandFord method, and the concentration was adjusted to 20 mg / L by adding PBS buffer.

[0030] The exosomes prepared in the above manner were used as control exosomes. Experimental exosomes A, B, and C were prepared in the same manner:

[0031] Experimental exosome A: The difference from the above control exosome preparation method is that 0.5 μg / mL prostaglandin E2 (PGE2) and 40 ng / mL mouse IL-4 were added to the culture medium during the first generation culture.

[0032] Experimental exosome B: The difference from the preparation method of exosome A is that 50 ng / mL lipopolysaccharide (LPS) was added to the culture medium during the first two days of the first generation culture, and then replaced with LPS-free culture medium (still containing 0.5 μg / mL PGE2 and 40 ng / mL mouse IL-4).

[0033] Experimental exosome C: The difference from the preparation method of exosome A is that 50 ng / mL lipopolysaccharide (LPS) was added to the culture medium during the first two days of the first generation culture, without PGE2 and mouse IL-4, and then replaced with a culture medium containing 1 μg / mL PGE2 and 40 ng / mL mouse IL-4.

[0034] The prepared exosomes were stored at -80°C after aliquoting.

[0035] Example 2 The prepared exosomes inhibit melanin synthesis in melanoma cells

[0036] The synthesis of intracellular melanin is mainly regulated by tyrosinase, which is the rate-limiting enzyme of the initial reaction of the melanin synthesis pathway. It can catalyze the hydroxylation of tyrosine to DOPA and oxidize DOPA to DOPAquinone, and finally form the reaction product melanin. In the tyrosinase activity inhibition experiment, the hydroxylation of tyrosine to DOPA or the oxidation of DOPA to DOPAquinone is affected by affecting the activity of tyrosinase, thereby affecting the synthesis of the final reaction product melanin. The melanin synthesis function of B16 mouse skin melanoma cells is basically the same as that of normal human skin melanocytes, and can be used to determine the inhibitory effect of the test substance on melanin synthesis.

[0037] B16 melanoma cells in the logarithmic growth phase were taken and the cell concentration was adjusted to 2×10 4 Cells / mL were inoculated in 96-well plates, 100 μL per well, and the medium was changed after 24 h. At the same time, different amounts (2 μL, 6 μL and 18 μL) of various exosomes prepared in Example 1 were added to the culture medium, and a blank control group without exosomes was set up. 8 wells per group. Continue to culture for 72 h, discard the supernatant, wash twice with PBS, take 2 replicate wells in each group for cell counting, and add 150 μL of 1 mol / L NaOH solution to the remaining 6 replicate wells, incubate in a 90 ° C water bath for 2 h, measure the absorbance value (OD value) of each well at a wavelength of 490 nm, and calculate the melanin synthesis inhibition rate (%) in melanocytes in each well according to the following formula.

[0038] Melanin synthesis inhibition rate (%) = [1-(OD value of exosome group / cell number) / (OD value of blank control group / cell number)] × 100%.

[0039] The results are shown in Figure 1 The control exosomes themselves have a certain ability to inhibit melanin synthesis. Exosome A can only show a stronger inhibitory ability than the control exosomes when the amount added is large (18μL). p< 0.05). Exosomes B and C had stronger inhibitory abilities, and showed significant differences from the control exosomes and exosomes A when the addition amount was 6 μL ( p< 0.05), and the difference between the exosomes and the control exosomes was more obvious when the addition amount was 18 μL ( p< 0.01). There was no significant difference in the inhibitory ability between exosomes B and C at each addition amount.

[0040] Example 3 Effects of LPS from different sources on melanin synthesis in melanoma cells

[0041] During our study of exosomes inhibiting melanin synthesis in melanoma cells, we noticed that exosomes prepared from different batches of LPS had different effects on melanin synthesis in melanoma cells. Later, we found that the reason was that the source bacteria of LPS were different. The LPS used in Example 1 was from Escherichia coli, while the LPS from Pseudomonas aeruginosa had the best effect.

[0042] Exosomes B and C were prepared according to the method of Example 1, except that the sources of LPS used were different, namely LPS from Salmonella enterica, Pseudomonas aeruginosa, Escherichia coli and Proteus (all purchased from Beijing Solebow Technology Co., Ltd., with catalog numbers L8661, L9190, L8852 and L8801, respectively).

[0043] Melanoma cell melanin synthesis test was performed as described in Example 2, and the amount of exosomes added was 6 μL. Figure 2 As shown. The inhibitory ability of exosomes prepared using LPS from Pseudomonas aeruginosa is significantly stronger, and there is a significant difference in the inhibitory ability of exosomes prepared using LPS from other sources ( p< 0.05), while no significant difference was found between the other three sources of LPS. It is currently unknown whether this difference is caused by differences in LPS structure or by different bacterial impurities carried by LPS from different sources.

[0044] Since most experiments did not show any difference between exosomes B and C, the exosomes used subsequently were prepared according to the preparation method of exosomes B.

[0045] Example 4 Skin whitening and moisturizing test

[0046] Skin care product preparation (100 mL): 5 g avocado oil, 15 g jojoba oil, 8 g sorbitan olivate, 2 g xanthan gum, 10 mL exosomes prepared in Example 3 (exosome B), and the balance deionized water, mixed well before use. At the same time, a skin care product containing the control exosomes prepared in Example 1 was prepared as a control.

[0047] The skin whitening condition is reflected by the skin melanin content (MI) value and the individual type angle (ITA°) value. The skin's moisturizing ability is reflected by the trans-epidermal water loss (TEWL) of the skin. The skin melanin content (MI) value is used to characterize the melanin index. The larger the MI value, the higher the skin melanin content. The ITA° value comprehensively reflects the lightness and tone of the skin. The L measured by the instrument Represents brightness and is used to indicate skin blackness and whiteness. The larger the value, the whiter the skin color. Represents the red-green color. Its change indicates the change in red-green color before and after the use of whitening products. +a Indicates red, -a Indicates green; b Represents the blue-yellow color. Its change indicates the change in the blue-yellow color of the skin before and after the use of whitening products. +b Indicates yellow, -b Indicates blue. 、a and b The numerical value can be used to calculate the ITA° value, thereby comparing the changes in skin color among people. The larger the ITA° value, the brighter the skin, and vice versa, the darker the skin. The TEWL value is an important parameter that reflects the water loss and barrier function of the skin. The lower the measured value, the less water loss, the better the moisturizing effect, and the better the barrier function of the skin.

[0048] Women aged 22-35 with no facial skin diseases and MI values ​​between 225-235 were selected as test subjects, a total of 50. They were randomly divided into 5 groups, 10 in each group, and the facial whitening effects of skin care products containing different exosomes were tested respectively. Test method: Select a fixed cheek area and apply the skin care product evenly twice a day, once in the morning and once in the evening, for a total of 6 weeks. During the test period, no other whitening products were used, and the face was exposed to sunlight for no more than 30 min on any day. Since the use of the skin care products of the present invention, the skin tester MexameterMX18 (CK, Germany) was used to detect the MI value, the CM-2600d colorimeter (Minolta, Japan) was used to detect the ITA° value, and the Tewameter TM300 water loss tester was used to detect the TEWL value at the end of each week. Wash the face with clean water before testing, measure 10 minutes after washing, and measure each measurement item 3 times during the test to take the average value.

[0049] The test results of MI value, ITA° value and TEWL value are shown in Figure 3-5 The results of each figure show that the exosomes prepared by the method of Example 3 of the present invention are superior to the control exosomes, among which Figure 3 and Figure 4 The results show that the exosomes prepared using LPS from Pseudomonas aeruginosa have a better effect, which is consistent with the results of the melanin synthesis inhibition test in Example 3.

[0050] Example 5 Selection of concentrations of PGE2, IL-4 and LPS

[0051] PGE2 has basically no effect on the above experimental results within the concentration range of 0.1-1μM. At higher concentrations, it can affect the production of exosomes. For example, at a concentration of 5μM, the production of exosomes can be reduced by about 10%. When the concentration is lower than 0.1μM, the prepared exosomes gradually become worse in terms of melanin inhibition ability. For example, exosome A prepared using 0.05 μg / mL of PGE2 (IL-4 concentration remains unchanged) failed to show any difference from the control exosomes when 18 μL was added in the melanin synthesis test.

[0052] When the concentration of IL-4 was lower than 10 nM, the prepared exosome A added at 18 μL in the melanin synthesis test did not show any difference from the control exosome, which was similar to the results of reducing PGE2 concentration. When the concentration was as high as 100 nM, no significant effect on the test results was found.

[0053] When the LPS concentration is lower than 10 ng / mL, its effect is basically not manifested; when the concentration is as high as 200 ng / mL, no obvious impact on the test results has been found.

Claims

1. A facial beauty composition comprising exosomes from mesenchymal stem cells and cosmetic excipients, wherein the exosomes are prepared by the following method: 1) culturing the mesenchymal stem cells in a culture medium supplemented with prostaglandin E2 and IL-4 until the cell confluence reaches 80-90%, and then performing cell subculture inoculation; 2) continuing to culture the mesenchymal stem cells after passage in a culture medium without adding prostaglandin E2 and IL-4, collecting the culture supernatant when the cell confluence is 60-70%, and separating exosomes with a diameter of 50 to 150 nm from the culture supernatant, The mesenchymal stem cells are human bone marrow mesenchymal stem cells; the concentration of prostaglandin E2 in the culture medium is 0.1-1 μM, and the concentration of IL-4 in the culture medium is 40-100 nM.

2. The facial cosmetic composition according to claim 1, wherein lipopolysaccharide is further added to the culture medium two days before the cell culture in step 1) at a concentration of 50-200 ng / mL.

3. The facial cosmetic composition according to claim 2, wherein the lipopolysaccharide is derived from Pseudomonas aeruginosa.

4. The facial cosmetic composition according to claim 1, wherein 100 mL of the facial cosmetic composition comprises: Avocado oil 5g, jojoba oil 15g, sorbitan olivate 8g, xanthan gum 2g, the exosomes 10 mL, the balance is deionized water, wherein the concentration of the exosomes is 20 mg / L based on the protein concentration determined by the BrandFord method.

5. A method for preparing a facial cosmetic composition, comprising: S1: Preparation of exosomes, including: 1) Cultivate mesenchymal stem cells in a medium supplemented with prostaglandin E2 and IL-4 until the cell confluence reaches 80-90%, then perform cell subculture; 2) continuing to culture the mesenchymal stem cells after passage in a culture medium without adding prostaglandin E2 and IL-4, collecting the culture supernatant when the cell confluence is 60-70%, separating exosomes with a diameter of 50 to 150 nm from the culture supernatant, and adjusting the exosome concentration to 20 mg / L in terms of protein concentration determined by the BrandFord method using PBS buffer; and S2: Preparing a skin care product comprising the exosomes, comprising: 5 g of avocado oil, 15 g of jojoba oil, 8 g of sorbitan olivate, 2 g of xanthan gum, 10 mL of the exosomes and deionized water were mixed evenly, wherein the amount of deionized water was such that the total amount of the skin care product was 100 mL. The mesenchymal stem cells are human bone marrow mesenchymal stem cells; the concentration of prostaglandin E2 in the culture medium is 0.1-1 μM, and the concentration of IL-4 in the culture medium is 40-100 nM.

6. The method according to claim 5, wherein lipopolysaccharide is added to the culture medium two days before the cell culture in step 1) at a concentration of 50-200 ng / mL.

7. Use of the facial cosmetic composition according to any one of claims 1 to 4 in skin whitening and / or moisturizing.

Citation Information

Patent Citations

  • Application of exosome in skin whitening preparation

    CN107007541A

  • Culture method for exosome capable of improving Treg cell activity

    CN113502262A

  • Face cream composition with effect of improving pachulosis and preparation method and application of face cream composition

    CN113908112A

  • Mesenchymal stem cell obtained through treatment of at least two cell factors of IL4, IL21 and IL27, exosome of mesenchymal stem cell and application of exosome

    CN115161276A

  • Freeze-dried powder containing mesenchymal stem cell exosome as well as preparation method and application of freeze-dried powder

    CN115282065A